Weekly treatment with low doses of the GLP-1 receptor agonist semaglutide (Ozempic) reduced alcohol consumption and craving ...
A new study (the first clinical trial of its kind) has shown that the GLP-1 agonist semaglutide — known by the brand name ...
Results showed that people craved and drank less alcohol when on the drug, according to the findings of a recent study.
A new study suggests that medications that have transformed the treatment of obesity may also help people drink less alcohol.